123 related articles for article (PubMed ID: 34117990)
1. Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen.
Jiang H; Geng L; Wan X; Song K; Tong J; Zhu X; Tang B; Yao W; Zhang X; Sun G; Zhang L; Sun Z; Liu H
Int J Hematol; 2021 Sep; 114(3):381-389. PubMed ID: 34117990
[TBL] [Abstract][Full Text] [Related]
2. [Risk Factors of Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation].
Zhang LY; Xiong YY; Liao MY; Xiao Q; Tang XQ; Luo XH; Zhang HB; Wang L; Liu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):250-256. PubMed ID: 38387930
[TBL] [Abstract][Full Text] [Related]
3. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation.
Han TT; Xu LP; Liu DH; Liu KY; Fu HX; Zhao XY; Zhao XS; Huang XJ
Am J Hematol; 2014 Jan; 89(1):55-61. PubMed ID: 24009106
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival.
Lunde LE; Dasaraju S; Cao Q; Cohn CS; Reding M; Bejanyan N; Trottier B; Rogosheske J; Brunstein C; Warlick E; Young JA; Weisdorf DJ; Ustun C
Bone Marrow Transplant; 2015 Nov; 50(11):1432-7. PubMed ID: 26168069
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
7. Effects and long-term follow-up of using umbilical cord blood-derived mesenchymal stromal cells in pediatric patients with severe BK virus-associated late-onset hemorrhagic cystitis after unrelated cord blood transplantation.
Tong J; Liu H; Zheng C; Zhu X; Tang B; Wan X; Yao W; Song K; Zhang L; Zhang X; Sun Z
Pediatr Transplant; 2020 Mar; 24(2):e13618. PubMed ID: 31944495
[TBL] [Abstract][Full Text] [Related]
8. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
Sanz J; Picardi A; Hernández Boluda JC; Martín C; Ferrá C; Nozzoli C; Gonzalez-Vicent M; Rambaldi A; Valcarcel D; Verdeguer A; Serrano D; de Heredia CD; Pascual MJ; de Paz R; Montesinos P; Bartolozzi B; Algarotti A; Sanz MA; Arcese W; Sanz GF;
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1387-92. PubMed ID: 23850652
[TBL] [Abstract][Full Text] [Related]
9. Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key.
Fu H; Xu L; Liu D; Zhang X; Liu K; Chen H; Wang Y; Han W; Han T; Huang X
Int J Hematol; 2013 Jul; 98(1):89-95. PubMed ID: 23632950
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning.
Lam W; Storek J; Li H; Geddes M; Daly A
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28199755
[TBL] [Abstract][Full Text] [Related]
11. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
[TBL] [Abstract][Full Text] [Related]
12. Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids.
Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2018 Jul; 97(7):1209-1217. PubMed ID: 29532160
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
Höller K; Fabeni L; Herling M; Holtick U; Scheid C; Knops E; Lübke N; Kaiser R; Pfister H; Di Cristanziano V
Eur J Haematol; 2017 Aug; 99(2):133-140. PubMed ID: 28401591
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
[TBL] [Abstract][Full Text] [Related]
15. Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: The 5-year single-center data.
Yuan H; Chen G; Xu J; Yang R; Muhashi M; Aizezi G; Jiang M
Front Oncol; 2022; 12():913802. PubMed ID: 35912244
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
[TBL] [Abstract][Full Text] [Related]
17. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
18. [Etiological Study of Late Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
Deng LL; Qiu KY; Liao XY; Liang YW; Huang K; Li Y; Xu HG; Fang JP; Zhou DH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1167-1173. PubMed ID: 30111425
[TBL] [Abstract][Full Text] [Related]
19. Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen.
Montoro J; Sanz J; Lorenzo JI; Montesinos P; Rodríguez-Veiga R; Salavert M; González E; Guerreiro M; Carretero C; Balaguer A; Gómez I; Solves P; Sanz GF; Sanz MA; Piñana JL
Eur J Haematol; 2019 Apr; 102(4):331-340. PubMed ID: 30506598
[TBL] [Abstract][Full Text] [Related]
20. Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
Sun Z; Liu H; Luo C; Geng L; Zheng C; Tang B; Zhu X; Tong J; Wang X; Ding K; Wan X; Zhang L; Yao W; Song K; Zhang X; Wu Y; Yang H; Han Y; Liu X; Zhu W; Wu J; Wang Z
Int J Cancer; 2018 Aug; 143(3):699-708. PubMed ID: 29473150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
